Renaissance Technologies’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-188,426
| Closed | -$1.4M | – | 3444 |
|
|
2026
Q1 | $1.4M | Buy |
188,426
+57,141
| +44% | +$372K | ﹤0.01% | 2093 |
|
|
2025
Q4 | $826K | Buy |
131,285
+15,400
| +13% | +$89.8K | ﹤0.01% | 2372 |
|
|
2025
Q3 | $452K | Buy |
115,885
+28,601
| +33% | +$117K | ﹤0.01% | 2842 |
|
|
2025
Q2 | $400K | Buy |
87,284
+1,700
| +2% | +$7.29K | ﹤0.01% | 2945 |
|
|
2025
Q1 | $418K | Sell |
85,584
-2,101
| -2% | -$12.8K | ﹤0.01% | 2812 |
|
|
2024
Q4 | $589K | Sell |
87,685
-42,022
| -32% | -$313K | ﹤0.01% | 2769 |
|
|
2024
Q3 | $1M | Buy |
129,707
+51,860
| +67% | +$313K | ﹤0.01% | 2445 |
|
|
2024
Q2 | $467K | Sell |
77,847
-55,960
| -42% | -$425K | ﹤0.01% | 2720 |
|
|
2024
Q1 | $1.21M | Buy |
133,807
+4,615
| +4% | +$42K | ﹤0.01% | 2371 |
|
|
2023
Q4 | $1.22M | Buy |
129,192
+68,322
| +112% | +$601K | ﹤0.01% | 2271 |
|
|
2023
Q3 | $724K | Sell |
60,870
-4,728
| -7% | -$83.8K | ﹤0.01% | 2514 |
|
|
2023
Q2 | $1.61M | Sell |
65,598
-3,970
| -6% | -$103K | ﹤0.01% | 2143 |
|
|
2023
Q1 | $2.18M | Buy |
69,568
+61,258
| +737% | +$3.54M | ﹤0.01% | 1980 |
|
|
2022
Q4 | $585K | Buy |
8,310
+3,345
| +67% | +$248K | ﹤0.01% | 2863 |
|
|
2022
Q3 | $427K | Sell |
4,965
-6,495
| -57% | -$631K | ﹤0.01% | 3021 |
|
|
2022
Q2 | $948K | Sell |
11,460
-15,760
| -58% | -$1.39M | ﹤0.01% | 2760 |
|
|
2022
Q1 | $4.52M | Sell |
27,220
-5,800
| -18% | -$832K | 0.01% | 1670 |
|
|
2021
Q4 | $5.52M | Sell |
33,020
-202
| -0.6% | -$22.8K | 0.01% | 1469 |
|
|
2021
Q3 | $2.87M | Buy |
33,222
+640
| +2% | +$42.4K | ﹤0.01% | 1818 |
|
|
2021
Q2 | $1.77M | Sell |
32,582
-30
| -0.1% | -$1.7K | ﹤0.01% | 2338 |
|
|
2021
Q1 | $1.94M | Sell |
32,612
-2,380
| -7% | -$139K | ﹤0.01% | 2249 |
|
|
2020
Q4 | $1.83M | Buy |
34,992
+2,120
| +6% | +$118K | ﹤0.01% | 2176 |
|
|
2020
Q3 | $1.59M | Sell |
32,872
-10,790
| -25% | -$516K | ﹤0.01% | 2264 |
|
|
2020
Q2 | $2.26M | Buy |
43,662
+36,520
| +511% | +$1.84M | ﹤0.01% | 2122 |
|
|
2020
Q1 | $311K | Sell |
7,142
-30
| -0.4% | -$1.22K | ﹤0.01% | 2963 |
|
|
2019
Q4 | $288K | Sell |
7,172
-898
| -11% | -$27.6K | ﹤0.01% | 3083 |
|
|
2019
Q3 | $265K | Buy |
+8,070
| New | +$390K | ﹤0.01% | 3069 |
|
Renaissance Technologies's KZR Position: Q2 2026 in Review
Renaissance Technologies sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 188,426 shares — an estimated $1.4M sold.
Renaissance Technologies first reported a position in KZR in Q3 2019 and held it in 27 quarters. The position peaked at $5.52M in Q4 2021. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.
- Renaissance Technologies reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
- Renaissance Technologies sold 188,426 Kezar Life Sciences shares in Q2 2026, an estimated $1.4M.
- Renaissance Technologies first reported a position in Kezar Life Sciences in Q3 2019 and held it in 27 quarters.
- Renaissance Technologies's Kezar Life Sciences position peaked at $5.52M in Q4 2021.
- 0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.